ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)

SHA:600479 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	929.22	1,344	1,998	1,240	632.88	755.37
Short-Term Investments	-	-	-	182	51.94	100.68
Trading Asset Securities	4.79	4.76	-	491.74	736.84	652.25
Cash & Short-Term Investments	934.01	1,349	1,998	1,914	1,422	1,508
Cash Growth	-48.12%	-32.47%	4.40%	34.61%	-5.74%	9.46%
Accounts Receivable	993.11	823.34	912.54	847.17	830.93	1,032
Other Receivables	93.53	15.75	28.26	27.83	31.23	31.24
Receivables	1,087	839.09	940.8	875	862.16	1,063
Inventory	474.18	485.94	534.14	598.99	547.78	496.79
Prepaid Expenses	-	-	0.24	0.73	3.44	0.25
Other Current Assets	44.35	54.65	41.4	125.07	82.22	120.59
Total Current Assets	2,539	2,729	3,514	3,513	2,917	3,189
Property, Plant & Equipment	556.39	561.31	516.08	547.02	630.19	490.5
Long-Term Investments	1,190	897.03	247.61	187.59	190.77	190.3
Goodwill	14.07	14.07	14.07	14.07	14.07	14.07
Other Intangible Assets	205.32	208.22	212.21	195.11	201.9	207.63
Long-Term Deferred Tax Assets	18.01	16.97	22.67	19.29	4.12	4.16
Long-Term Deferred Charges	71.63	67.44	71.73	71.41	76.98	86.86
Other Long-Term Assets	66.32	62.33	78.03	86.64	24.93	45.84
Total Assets	4,661	4,556	4,677	4,635	4,060	4,229
Accounts Payable	614.2	565.64	647.49	780.92	511.67	623.04
Accrued Expenses	88.46	217.73	387.29	376.04	267.41	225.54
Short-Term Debt	6.23	11.9	56.69	58.13	67.09	134.9
Current Portion of Long-Term Debt	-	-	5	3.5	3	1
Current Portion of Leases	-	-	16.56	17.84	18.55	-
Current Income Taxes Payable	33.56	-	37.28	31.29	23.89	32.72
Current Unearned Revenue	79.02	95.27	123.61	131.21	99.59	101.2
Other Current Liabilities	543.67	442.25	267.9	298.3	237.22	259.36
Total Current Liabilities	1,365	1,333	1,542	1,697	1,228	1,378
Long-Term Debt	-	-	7	12	15.5	19.5
Long-Term Leases	27.12	25.96	31.46	32.76	44.79	-
Long-Term Unearned Revenue	32.27	33.66	38.04	44.44	51.27	51.82
Long-Term Deferred Tax Liabilities	16.2	17.65	24.72	24.06	13.22	10.55
Other Long-Term Liabilities	7.09	7.09	5.19	5.19	5.19	5.19
Total Liabilities	1,448	1,417	1,650	1,818	1,360	1,467
Common Stock	424	424	428.92	429.81	418.51	418.51
Additional Paid-In Capital	605.25	603.25	631.18	635.44	585.49	585.44
Retained Earnings	1,503	1,450	1,363	1,192	1,146	1,262
Treasury Stock	-16.56	-16.56	-35.02	-41.81	-	-
Comprehensive Income & Other	1.58	1.58	1.59	1.4	0.75	0.75
Total Common Equity	2,517	2,462	2,390	2,217	2,150	2,267
Minority Interest	696.02	676.87	637.08	600.07	549.55	495.21
Shareholders' Equity	3,213	3,139	3,027	2,817	2,700	2,762
Total Liabilities & Equity	4,661	4,556	4,677	4,635	4,060	4,229
Total Debt	33.36	37.85	116.71	124.24	148.93	155.4
Net Cash (Debt)	900.65	1,311	1,881	1,789	1,273	1,353
Net Cash Growth	-46.84%	-30.29%	5.13%	40.60%	-5.93%	-0.19%
Net Cash Per Share	2.18	3.17	4.45	4.18	3.04	3.23
Filing Date Shares Outstanding	423.89	382.44	428.92	428.12	418.51	418.51
Total Common Shares Outstanding	423.89	382.44	428.92	428.12	418.51	418.51
Working Capital	1,174	1,396	1,973	1,816	1,689	1,812
Book Value Per Share	5.94	6.44	5.57	5.18	5.14	5.42
Tangible Book Value	2,298	2,240	2,163	2,008	1,934	2,045
Tangible Book Value Per Share	5.42	5.86	5.04	4.69	4.62	4.89
Buildings	-	-	780.42	765.95	650.15	630.69
Machinery	-	-	411.71	395.8	436.31	403.76
Construction In Progress	-	-	6.12	5.78	94.34	43.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.